KALEIGH RAPOZA: Open Payments
NPI 1174200976 · JOHNSTON, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,914 in 310 payments from 22 companies in 2025. Trend: 2023 $2,563 · 2024 $5,557 · 2025 $5,914
Food & beverage: $5,760Education: $153
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 79 | $1,317 |
| ABBVIE INC. | 48 | $814 |
| LEO Pharma Inc. | 30 | $723 |
| Galderma Laboratories, L.P. | 19 | $413 |
| Regeneron Healthcare Solutions, Inc. | 13 | $403 |
| UCB, Inc. | 14 | $310 |
| Novartis Pharmaceuticals Corporation | 13 | $259 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $256 |
| Amgen Inc. | 12 | $253 |
| Organon LLC | 9 | $194 |
Products named: TREMFYA, ADBRY, DUPIXENT, SKYRIZI, NEMLUVIO, RINVOQ, Bimzelx, OTEZLA.
Industry payments across RI — which companies pay providers there.
